1887

Abstract

An audit was performed on the laboratory diagnosis of Lyme disease in Scotland. The problem of a significant number of patients with clinical symptoms of Lyme disease being reported as seronegative or equivocal by the confirmatory Western blot test was identified. Comparisons of current practice were made with American and European standards, and the Western blot scoring system revised. When applied retrospectively (April 2003 to March 2004), 39 (33 %) of 116 serum samples previously negative or equivocal became weak positive or stronger. Thirty-one (80 %) of these 39 samples were from patients with clinical details suggestive of early Lyme disease. The changes were implemented and assessed prospectively for 6 months. There was a significant increase in the proportion of equivocal results, with fewer negatives compared to the same time period 1 year previously. This audit has helped clinicians in the diagnosis of Lyme disease and the management of these patients in Scotland.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.46003-0
2005-12-01
2019-11-12
Loading full text...

Full text loading...

/deliver/fulltext/jmm/54/12/JM541204.html?itemId=/content/journal/jmm/10.1099/jmm.0.46003-0&mimeType=html&fmt=ahah

References

  1. Centers for Disease Control and Prevention ( 1995;). Recommendations for test performance and interpretation from the 2nd National Conference on serologic diagnosis of Lyme disease. MMWR Morb Mortal Wkly Rep 44, 590–591.
    [Google Scholar]
  2. Cutler, S. J. & Wright, D. J. M. ( 1994;). Predictive value of serology in diagnosing Lyme borreliosis. J Clin Pathol 47, 344–349.[CrossRef]
    [Google Scholar]
  3. Davidson, M. M., Chisholm, S. M., Wiseman, A. D., Joss, A. W. L. & Ho-Yen, D. O. ( 1996;). Improved serodiagnosis of Lyme disease. J Clin Pathol Mol Pathol 49, M80–M84.[CrossRef]
    [Google Scholar]
  4. Davidson, M. M., Evans, R. & Ho-Yen, D. O. ( 2003;). Lyme disease: gold for Scotland and bronze for USA. Scot Med J 48, 6–9.
    [Google Scholar]
  5. Dressler, F., Whalen, A. J., Reinhardt, B. N. & Steere, A. C. ( 1993;). Western blotting in the serodiagnosis of Lyme disease. J Infect Dis 167, 392–400.[CrossRef]
    [Google Scholar]
  6. Engstrom, S. M., Shoop, E. & Johnson, R. C. ( 1995;). Immunoblot interpretation criteria for serodiagnosis of early Lyme disease. J Clin Microbiol 33, 419–427.
    [Google Scholar]
  7. Hauser, U., Lehnert, G., Lobentanzer, R. & Wilske, B. ( 1997;). Interpretation criteria for standardized Western blots for three European species of Borrelia burgdorferi sensu lato. J Clin Microbiol 35, 1433–1444.
    [Google Scholar]
  8. Ho-Yen, D. O., Bennet, A. J., Chisholm, S. & Deacon, A. G. ( 1990;). Lyme disease in the Highlands. Scot Med J 35, 168–170.
    [Google Scholar]
  9. Joss, A. W. L., Davidson, M. M., Ho-Yen, D. O. & Ludbrook, A. ( 2003;). Lyme disease – what is the cost for Scotland? Public Health 117, 264–273.[CrossRef]
    [Google Scholar]
  10. Pfister, H. W., Wilske, B. & Weber, K. ( 1994;). Lyme borreliosis: basic science and clinical aspects. Lancet 343, 1013–1016.[CrossRef]
    [Google Scholar]
  11. Robertson, J., Guy, E., Andrews, N. & 9 other authors ( 2000;). A European multicenter study of immunoblotting in serodiagnosis of Lyme disease. J Clin Microbiol 38, 2097–2102.
    [Google Scholar]
  12. Steere, A. C. ( 2001;). Lyme disease. N Engl J Med 345, 115–125.[CrossRef]
    [Google Scholar]
  13. Wilske, B. ( 2003;). Diagnosis of Lyme borreliosis in Europe. Vector Borne Zoonotic Dis 3, 215–227.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.46003-0
Loading
/content/journal/jmm/10.1099/jmm.0.46003-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error